PMC Links for GEO Profiles (Select 27140477) - PMC

Links from GEO Profiles

Items: 1 to 20 of 114

<< First< Prev

Page of 6

Select item 112181171.

Hypoimmunogenic human iPSCs expressing HLA-G, PD-L1, and PD-L2 evade innate and adaptive immunity

Norihiro Tsuneyoshi, Tomonori Hosoya, Yuriko Takeno, Kodai Saitoh, Hidetaka Murai, Naoki Amimoto, Rie Tatsumi, Sono Watanabe, Yudai Hasegawa, Eri Kikkawa, Kumiko Goto, Fusako Nishigaki, Kouichi Tamura, Hironobu Kimura

Stem Cell Res Ther. 2024; 15: 193. Published online 2024 Jul 2. doi: 10.1186/s13287-024-03810-4

PMCID:: PMC11218117

Abstract Article PDF–1.9M

Select item 109911092.

An alternatively spliced PD-L1 isoform PD-L1∆3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy response

Didem Naz Dioken, Ibrahim Ozgul, Irem Yilmazbilek, Mustafa Cengiz Yakicier, Ezgi Karaca, Ayse Elif Erson-Bensan

Cancer Immunol Immunother. 2023 Dec; 72(12): 4065–4075. Published online 2023 Sep 28. doi: 10.1007/s00262-023-03543-y

PMCID:: PMC10991109

Abstract Article PDF–2.2M

Select item 105688793.

Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines

Nyanbol Kuol, Janusz Godlewski, Zbigniew Kmiec, Sara Vogrin, Sarah Fraser, Vasso Apostolopoulos, Kulmira Nurgali

BMC Cancer. 2023; 23: 971. Published online 2023 Oct 12. doi: 10.1186/s12885-023-11410-3

PMCID:: PMC10568879

Abstract Article PDF–10M

Select item 100606384.

Pan-cancer analysis identifies PD-L2 as a tumor promotor in the tumor microenvironment

Jingfang Lv, Zheng Jiang, Junhu Yuan, Meng Zhuang, Xu Guan, Hengchang Liu, Yefeng Yin, Yiming Ma, Zheng Liu, Hongying Wang, Xishan Wang

Front Immunol. 2023; 14: 1093716. Published online 2023 Mar 16. doi: 10.3389/fimmu.2023.1093716

PMCID:: PMC10060638

Abstract Article PDF–15M

Select item 100504155.

Evolving landscape of PD-L2: bring new light to checkpoint immunotherapy

Yuqing Wang, Jiang Du, Zhenyue Gao, Haoyang Sun, Mei Mei, Yu Wang, Yu Ren, Xuan Zhou

Br J Cancer. 2023 Mar 30; 128(7): 1196–1207. Published online 2022 Dec 15. doi: 10.1038/s41416-022-02084-y

PMCID:: PMC10050415

Abstract Article PDF–1.2M

Select item 100339376.

Assessment of community efforts to advance network-based prediction of protein–protein interactions

Xu-Wen Wang, Lorenzo Madeddu, Kerstin Spirohn, Leonardo Martini, Adriano Fazzone, Luca Becchetti, Thomas P. Wytock, István A. Kovács, Olivér M. Balogh, Bettina Benczik, Mátyás Pétervári, Bence Ágg, Péter Ferdinandy, Loan Vulliard, Jörg Menche, Stefania Colonnese, Manuela Petti, Gaetano Scarano, Francesca Cuomo, Tong Hao, Florent Laval, Luc Willems, Jean-Claude Twizere, Marc Vidal, Michael A. Calderwood, Enrico Petrillo, Albert-László Barabási, Edwin K. Silverman, Joseph Loscalzo, Paola Velardi, Yang-Yu Liu

Nat Commun. 2023; 14: 1582. Published online 2023 Mar 22. doi: 10.1038/s41467-023-37079-7

PMCID:: PMC10033937

Abstract Article PDF–1.5M

Select item 99529487.

Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Maysaa Abdulla, Christer Sundström, Cecilia Lindskog, Peter Hollander

Biomolecules. 2023 Feb; 13(2): 240. Published online 2023 Jan 27. doi: 10.3390/biom13020240

PMCID:: PMC9952948

Abstract Article PDF–1.7M

Select item 96433738.

FAK promotes stromal PD-L2 expression associated with poor survival in pancreatic cancer

Catherine Davidson, David Taggart, Andrew H. Sims, David W. Lonergan, Marta Canel, Alan Serrels

Br J Cancer. 2022 Nov 9; 127(10): 1893–1905. Published online 2022 Sep 22. doi: 10.1038/s41416-022-01966-5

PMCID:: PMC9643373

Abstract Article PDF–2.5M

Select item 96327579.

Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/PD-L1/PD-L2 alterations

Marthe Minderman, Avital Amir, Willem Kraan, Esther J. M. Schilder-Tol, Monique E. C. M. Oud, Cornelis G. Scheepstra, Arnold L. Noorduyn, Philip M. Kluin, Marie José Kersten, Marcel Spaargaren, Steven T. Pals

Blood. 2021 Sep 30; 138(13): 1194–1197. doi: 10.1182/blood.2021011366

PMCID:: PMC9632757

Article

Select item 954635710.

Exome sequencing identifies PD‐L2 as a potential predisposition gene for lymphoma

Jianming Shao, Lei Gao, Marco L. Leung, Bailey Gallinger, Cara Inglese, M. Stephen Meyn, Daniela Del Gaudio, Soma Das, Zejuan Li

Hematol Oncol. 2022 Aug; 40(3): 475–478. Published online 2022 May 29. doi: 10.1002/hon.3033

PMCID:: PMC9546357

Abstract Article PDF–625K

Select item 936118911.

High Expression of Programmed Death Ligand 1 and Programmed Death Ligand 2 in Ophthalmic Sebaceous Carcinoma: The Case for a Clinical Trial of Checkpoint Inhibitors

NATALIE WOLKOW, FREDERICK A. JAKOBIEC, AMIR H. AFROGHEH, SARA I. PAI, WILLIAM C. FAQUIN

Am J Ophthalmol. Author manuscript; available in PMC 2022 Aug 9.

Published in final edited form as: Am J Ophthalmol. 2020 Dec; 220: 128–139. Published online 2020 Jul 28. doi: 10.1016/j.ajo.2020.07.031

PMCID:: PMC9361189

Abstract Article PDF–1.1M

Select item 935720312.

Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired Resistance

Zhentao Yang, Yan Wang, Sixue Liu, Weixian Deng, Shirley H. Lomeli, Gatien Moriceau, James Wohlschlegel, Marco Piva, Roger S. Lo

Cancer Discov. 2022 Aug 5; 12(8): 1942–1959. Published online 2022 May 31. doi: 10.1158/2159-8290.CD-21-1463

PMCID:: PMC9357203

Abstract Article PDF–6.8M

Select item 934857613.

Chr21 protein–protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer’s disease

Julia Viard, Yann Loe-Mie, Rachel Daudin, Malik Khelfaoui, Christine Plancon, Anne Boland, Francisco Tejedor, Richard L Huganir, Eunjoon Kim, Makoto Kinoshita, Guofa Liu, Volker Haucke, Thomas Moncion, Eugene Yu, Valérie Hindie, Henri Bléhaut, Clotilde Mircher, Yann Herault, Jean-François Deleuze, Jean-Christophe Rain, Michel Simonneau, Aude-Marie Lepagnol-Bestel

Life Sci Alliance. 2022 Dec; 5(12): e202101205. Published online 2022 Aug 1. doi: 10.26508/lsa.202101205

PMCID:: PMC9348576

Abstract Article PDF–3.0M

Select item 897727414.

PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules

Yue Zhang, Xianlong Chen, Shengwei Mo, Heng Ma, Zhaohui Lu, Shuangni Yu, Jie Chen

J Pathol Clin Res. 2022 May; 8(3): 257–267. Published online 2022 Jan 17. doi: 10.1002/cjp2.259

PMCID:: PMC8977274

Abstract Article PDF–1.2M

Select item 892902915.

Regulation of Immunity in Clear Cell Renal Carcinoma: Role of PD-1, PD-L1, and PD-L2

Liudmila Spirina, Zahar Yurmazov, Evgeny Usynin, Irina Kondakova, Ekaterine Ladutko, Evgeny Choynzonov

Curr Issues Mol Biol. 2021 Sep; 43(2): 1072–1080. Published online 2021 Sep 6. doi: 10.3390/cimb43020076

PMCID:: PMC8929029

Abstract Article PDF–665K

Select item 886725816.

Differential expression of PD-L1 and PD-L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non-small cell lung cancer

Ryota Sumitomo, Cheng-Long Huang, Masaaki Fujita, Hiroyuki Cho, Hiroshi Date

Oncol Rep. 2022 Apr; 47(4): 73. Published online 2022 Feb 15. doi: 10.3892/or.2022.8284

PMCID:: PMC8867258

Abstract Article PDF–2.6M

Select item 874459017.

Human Cytomegalovirus miR-UL70-3p Downregulates the H₂O₂-Induced Apoptosis by Targeting the Modulator of Apoptosis-1 (MOAP1)

Abhishek Pandeya, Raj Kumar Khalko, Anup Mishra, Nishant Singh, Sukhveer Singh, Sudipta Saha, Sanjay Yadav, Sangeeta Saxena, Sunil Babu Gosipatala

Int J Mol Sci. 2022 Jan; 23(1): 18. Published online 2021 Dec 21. doi: 10.3390/ijms23010018

PMCID:: PMC8744590

Abstract Article PDF–9.4M

Select item 867122218.

Structural evidence that MOAP1 and PEG10 are derived from retrovirus/retrotransposon Gag proteins

Katarzyna Zurowska, Ayaan Alam, Barbie K. Ganser-Pornillos, Owen Pornillos

Proteins. Author manuscript; available in PMC 2023 Jan 1.

Published in final edited form as: Proteins. 2022 Jan; 90(1): 309–313. Published online 2021 Aug 21. doi: 10.1002/prot.26204

PMCID:: PMC8671222

Abstract Article PDF–1.3M

Select item 865641919.

Inhibition of PI3Kδ Differentially Regulates Poly I:C– and Human Metapneumovirus–Induced PD–L1 and PD–L2 Expression in Human Bronchial Epithelial Cells

Tomohiro Ogawa, Keiko Kan-o, Ayaka Shiota, Akitaka Fujita, Yumiko Ishii, Satoru Fukuyama, Koichiro Matsumoto

Front Immunol. 2021; 12: 767666. Published online 2021 Nov 25. doi: 10.3389/fimmu.2021.767666

PMCID:: PMC8656419

Abstract Article PDF–11M

Select item 864533820.

Phospho-β-catenin expression in primary and metastatic melanomas and in tumor-free visceral tissues, and associations with expression of PD-L1 and PD-L2.

Joel Pinczewski, Rebecca C. Obeng, Craig L. Slingluff, Jr., Victor H. Engelhard

Pathol Res Pract. Author manuscript; available in PMC 2022 Aug 1.

Published in final edited form as: Pathol Res Pract. 2021 Aug; 224: 153527. Published online 2021 Jun 17. doi: 10.1016/j.prp.2021.153527

PMCID:: PMC8645338

Abstract Article PDF–2.0M

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from GEO Profiles

Items: 1 to 20 of 114

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity